Movement Alert｜WUXI XDC Falls 3.03% in Regular Trading, Life Sciences Tools & Services Weakness Weighs on Shares

Market Focus10:18

On October 29, WUXI XDC fell 3.03% in Regular Trading, trading at HK$67.05 per share, with turnover of HK$68.80 million.

The move aligns with broader weakness across the Life Sciences Tools & Services segment rather than a newly disclosed company-specific negative catalyst. In the sector, GENSCRIPT B-1K rose 1.63%, WUXI APPTEC fell 1.78%, WUXI BIO fell 3.41%, JOINN fell 6.04%, and INSILICO fell 1.91%.

Recent disclosed fundamentals remained solid: first-half revenue was RMB3.701 billion, up 37.0% year over year, while adjusted net profit rose 37.4% to RMB1.027 billion. Earlier research coverage maintained a Buy rating with a HK$97.90 target price, and highlighted a potential first FDA inspection of its Wuxi facility in the first quarter next year as a key commercialization milestone.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment